NCT06035744
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06035744
Title CLN-617 Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Cullinan Oncology, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
Orlando Health Orlando Florida 32806 United States Details
University of Chicago Chicago Illinois 60637 United States Details
MD Anderson Houston Texas 77030 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field